Brain supplements that claim to boost cognitive function are increasingly popular, growing from a $4 billion industry of about 4,000 unique products to a $40 billion industry with as many as 80,000 different products on the market. [Read more…] about Study: Over-the-counter “brain enhancement” supplements in the US found both to a) contain multiple unapproved drugs and b) lack some ingredients listed on the label
Moderate drinking tied to lower levels of Alzheimer’s brain protein (Business Standard):
“Korean researchers studied 414 men and women, average age 71, who were free of dementia or alcohol-related disorders. All underwent physical exams, tests of mental acuity, and positron emission tomography (PET) and magnetic resonance imaging (MRI) scans. They were carefully interviewed about their drinking habits.
The study, in PLOS Medicine, measured drinking in “standard drinks” — 12 ounces of beer, five ounces of wine, or one-and-a-half ounces of hard liquor. Compared with abstainers, those who drank one to 13 standard drinks a week had a 66 per cent lower rate of beta amyloid deposits in their brains. [Read more…] about Study: Moderate lifetime drinking may lead to lower Alzheimer-related beta amyloid deposits in the brain
“The National Institutes of Health (NIH) launched 110 new brain research projects in the fiscal year ending last September (2017) with the first portion of the $1.5 billion over 10 years it will hopefully receive from the 21st Century Cures Act, which spread a total of $4.8 billion over four NIH programs. That is money over and above the NIH annual appropriation from Congress. The other three “Innovation Funds” are: Precision Medicine, Cancer Moonshot, and Regenerative Medicine.
The $1.5 billion in new Brain Research through Advancing Innovative Neuro-technologies (BRAIN) research money seems particularly important given the announcement in January that Pfizer was ending its Alzheimer’s research program [Read more…] about The NIH starts spending $1.5 billion in new Brain Research through Advancing Innovative Neuro-technologies (BRAIN) projects
What does the future hold for the war on Alzheimer’s? (The Globe and Mail):
“After spending huge sums on clinical trails in recent years, the pharmaceutical industry has failed to find a drug that can halt the mind-robbing disease. And this month, Pfizer announced it is ending its Alzheimer’s research, although other companies haven’t thrown in the towel yet. But other prevention measures are being explored.
Several Toronto hospitals are involved in an ambitious $10-million, five-year study to determine whether a combination of cognitive remediation – mental exercises – plus electrical stimulation of the brain can delay [Read more…] about With pharma exiting Alzheimer’s research, new hope (and urgency) seen in the combination of brain training and transcranial direct current stimulation (tDCS)
June is Alzheimer’s & Brain Awareness Month, so let me share these 20 Must-Know Facts to Harness Neuroplasticity & Improve Brain Health that come from the hundreds of scientific and medical studies we analyzed [Read more…] about 20 Must-Know Facts to Harness Neuroplasticity and Improve Brain Health
(Editor’s Note: In order to help readers familiarize themselves with the work and thinking of Dr. Michael Merzenich, one of the winners of the 2016 Kavli Prize in Neuroscience for groundbreaking work on neuroplasticity, we are condensing and republishing the comprehensive conversation that Dr. Merzenich and Alvaro Fernandez had in 2009, in preparation for the inaugural SharpBrains Virtual Summit.)
Dr. Michael Merzenich, Emeritus Professor at UCSF, is a leading pioneer in brain plasticity research. In the late 1980s, Dr. Merzenich was on the team that invented the cochlear implant. In 1996, he was the founding CEO of Scientific Learning Corporation, and in 2004 became co-founder and [Read more…] about Dr. Michael Merzenich: To harness Neuroplasticity for cognitive enhancement, we need to think “Fitness” more than “Games”